Submit your email to push it up the queue
Asahi Kasei Medical Co., Ltd., a prominent subsidiary of Asahi Kasei Corporation, is headquartered in Japan and operates extensively across Asia, Europe, and North America. Founded in 1948, the company has established itself as a leader in the medical device and healthcare industry, focusing on innovative solutions in dialysis, blood management, and regenerative medicine. With a commitment to enhancing patient care, Asahi Kasei Medical offers a range of unique products, including advanced dialysis equipment and biocompatible materials. Their dedication to research and development has led to significant milestones, positioning them as a trusted name in the medical field. Recognised for their quality and reliability, Asahi Kasei Medical continues to make strides in improving healthcare outcomes globally.
How does Asahi Kasei Medical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Asahi Kasei Medical Co., Ltd.'s score of 70 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Asahi Kasei Medical Co., Ltd., headquartered in Japan (JP), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Asahi Kasei Corporation, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from Asahi Kasei Medical Co., Ltd., it is important to note that emissions data and performance metrics may be cascaded from its parent company, Asahi Kasei Corporation. This cascading occurs at a level 2 relationship, meaning that the parent company’s initiatives and performance may inform the subsidiary's climate strategies. Asahi Kasei Corporation has been active in addressing climate change, and any relevant targets or achievements in emissions reduction would likely be applicable to Asahi Kasei Medical Co., Ltd. as part of the corporate family. However, specific details regarding these initiatives or targets are not provided in the available data. In summary, while Asahi Kasei Medical Co., Ltd. does not currently disclose its own emissions data or reduction targets, it is positioned within a corporate structure that may influence its climate commitments through the practices of its parent company.
Access structured emissions data, company-specific emission factors, and source documents
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | - | 0,000,000,000 | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Scope 2 | - | 0,000,000,000 | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Asahi Kasei Medical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.